Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort ascending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort ascending Business Functional Area Date Posted
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 07, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 18, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 21, 2024
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 23, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Expert Science & Technology Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Sep 03, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Sep 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 20, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Oct 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Oct 08, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Switzerland Corporate Affairs Corporate BD&L & Strategic Planning Oct 15, 2024
Comms & Engagement Manager Amsterdam Netherlands Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany Corporate Affairs Innovative Medicines Facilities & Administration Sep 02, 2024
Patient Engagement Lead İstanbul Kavacık Turkey Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Manager, Post Production & Video Services Hyderabad (Office) India Corporate Affairs CTS Communications & Public Affairs Oct 04, 2024
Chef, Communications corporatives Montreal Canada Corporate Affairs CTS Communications & Public Affairs Oct 21, 2024
Manager, Corporate Communications Montreal Canada Corporate Affairs CTS Communications & Public Affairs Oct 21, 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs Oct 22, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Oct 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
Government Affairs Manager Moscow (City) Russian Fed. Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
Director of Commercial Policy Communications and Media Relations, Europe Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Oct 24, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Oct 18, 2024
Senior Scientist I/II, Protein Engineering-REQ10019930 Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Director of Applied AI Research | Data Science (Drug Discovery) Cambridge (USA) USA Biomedical Research Pharma Research Data and Digital Oct 16, 2024
Sr Principal Observability Engineer Hyderabad (Office) India Biomedical Research Pharma Research Technology Transformation Oct 17, 2024
Site Head – Biomedical Research India Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 17, 2024
Senior Expert Data Science Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Oct 08, 2024
Expert Data Science Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Oct 08, 2024
Scientific Manager - Radioligand Therapy & Oncology Pharmacology (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 08, 2024
Research Scientist, Kidney Pharmacology (BS or MS) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 09, 2024
Senior Scientist, Comparative Medicine- (GEMs) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 10, 2024
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Associate Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 11, 2024
Clinical Sciences Trial Leader (Multiple Roles) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 12, 2024
Asset Strategy Lead - Automation (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 14, 2024
Research Scientist, Chemistry (BS or MS) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 30, 2024
Next Generation Scientist 2025 Basel (City) Switzerland Biomedical Research Innovative Medicines Others Oct 01, 2024
Research Scientist II San Diego USA Biomedical Research Pharma Research Research & Development Oct 01, 2024
Bioreactions Team Leader 80-100%* Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 02, 2024
Senior Investigator - Pharmacokinetics Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Sep 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia